Nature Clinical Practice Rheumatology | 2009(02) articles
- The uncertain pathway to new therapeutics for SLE
- Switching off BAFF in the joints can inhibit arthritis development
- Intraperitoneal delivery of nanoparticles targets TNF expression
- Use of PET with macrophage imaging to detect joint inflammation in RA
- Distinct clinical features of polymyalgia rheumatica
- Influence of infliximab on cardiovascular risk factors in patients with RA
- Lovastatin absorbed through the skin accelerates fracture healing in rats
- IN BRIEFS
- RADIATE : more treatment options for patients with an inadequate response to tumor necrosis factor antagonists
- Is there a role for everolimus in the treatment of RA?
- Are statins useful for treating vascular involvement in systemic sclerosis?
- Is denosumab better than alendronate in the treatment of osteoporosis?
- Do the benefits of alendronate for premenopausal women on high-dose glucocorticoids outweigh the risks?
- Imaging in osteoarthritis trials : useful or just expensive?
- Deficiencies in current evaluations of the cost-effectiveness of biologic agents for RA
- Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T cells
- New insights into the pathogenesis and genetics of psoriatic arthritis
- Treating skeletal pain : limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative
- The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease
- Neurocognitive impairment in children and adolescents with systemic lupus erythematosus